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Abstract 25 
Repeated ocular infections with Chlamydia trachomatis trigger the development of trachoma, the most 26 
common cause of infectious blindness worldwide. Water-filtered infrared A (wIRA) has shown positive 27 
effects on cultured cells and human skin. Our aim was to evaluate the potential of wIRA as a possible 28 
non-chemical treatment for trachoma patients. We both modeled ocular chlamydial infections using C. 29 
trachomatis B to infect human conjunctival epithelial cells (HCjE) and studied the effects of wIRA on 30 
non-infected ocular structures with two ex vivo eye models. We focused on the temperature 31 
development during wIRA irradiation in cell culture and perfused pig eyes to exclude potentially 32 
harmful side effects. Furthermore, cell viability of HCjE and cytotoxicity in mouse retina explants were 33 
analyzed. 34 
We demonstrated a significant wIRA-dependent reduction of chlamydial infectivity in HCjE cells. 35 
Moreover, we observed that wIRA treatment of HCjE prior to infection was sufficient to inhibit 36 
chlamydial infectivity and that visible light enhances the effect of wIRA. Irradiation did not reduce cell 37 
viability and there was no indication of retinal damage post treatment. Additionally, temperatures 38 
during wIRA exposure did not markedly exceed physiological eye temperatures, suggesting that 39 
hyperthermia-related lesions are unlikely. For clinical applications, further exploration of wIRA as a 40 
non-chemical treatment device in an experimental animal model is essential. 41 
 42 
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1. Introduction  45 
Trachoma is a human infectious ocular disease and a major cause of preventable blindness 46 
worldwide, specifically in Africa, Asia, Central and South America, Australia and the Middle East. 47 
Approximately 229 million people are currently at risk of contracting trachoma according to the World 48 
Health Organization (WHO). Conjunctival infection with Chlamydia (C.) trachomatis ocular strains A, B 49 
or C marks the onset of trachoma and is followed by four clinical stages: i) papillary hypertrophy and 50 
lymphoid follicles (active trachoma), affecting an estimated 21 million people, ii) accumulation of scar 51 
tissue in the conjunctiva, iii) eyelid distortion and scarring of the cornea through rubbing lashes 52 
(trichiasis, affecting approximately 7.3 million people) and iv) corneal opacification leading to 53 
irreversible blindness, with approximately 1.2 million people affected worldwide (1-3). 54 
To date, the SAFE strategy is used in an attempt to eliminate endemic blinding trachoma, and 55 
includes Surgery for trachomatous trichiasis, Antibiotic treatment, Facial cleanliness and 56 
Environmental improvement such as general community hygiene, adequate water supply and 57 
construction of sanitary facilities (2–4). For individuals suffering from active trachoma, antibiotic 58 
treatment with azithromycin or doxycycline is the most common therapy and is often applied via mass 59 
drug administration (MDA) in endemic regions as part of the elimination program (4). A study by West 60 
et al. demonstrated that even after multiple MDA treatments, one third of the patients still had eye 61 
infections with C. trachomatis. Although they did not find evidence for azithromycin resistance, the 62 
possibility could not be ruled out completely (5). Antimicrobial resistance in general has become a 63 
major public health concern in recent years. Pathogens have developed resistance to multiple classes 64 
of antibiotics, so the limitation of antibiotic use is encouraged worldwide, especially in food production 65 
herds (6).  66 
Of particular interest is the emergence of tetracycline resistance in C. suis, a growing problem in the 67 
pig rearing industry and probably the result of excessive tetracycline use for therapeutic purposes and 68 
as growth promoters in livestock since the 1950s (7–11). C. suis is primarily known to inapparently 69 
infect the porcine gastrointestinal tract with a prevalence of up to 90% in fattening pigs (12). Together 70 
with C. trachomatis, C. suis belongs to the obligate intracellular and Gram-negative bacterial family 71 
Chlamydiaceae, which is characterized by a unique biphasic lifecycle consisting of infectious 72 
elementary bodies (EBs) and intracellular, dividing reticulate bodies (RBs) (12,13). Alarmingly, mixed 73 
infections with C. trachomatis and C. suis have been reported in Nepalese trachoma patients, while 74 
co-infection of the two closely related species generated tetracycline resistant C. trachomatis strains in 75 
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vitro (14,15). Taking these findings together, mixed infection with tetracycline resistant C. suis and 76 
ocular C. trachomatis strains may amplify the emergence of therapy-resistant trachoma strains. 77 
Therefore, the development of alternative, preferably non-chemical, treatment methods may aid 78 
achievement of the WHO goal established in 1997 to eliminate trachoma by the year 2020 (3). 79 
Water-filtered infrared A radiation (wIRA) with a radiation spectrum ranging from 780 to 1400 nm has 80 
been used successfully, either alone or in combination with visible light (VIS), to aid the healing 81 
process of acute and chronic wounds, improving tissue oxygen partial pressure and perfusion, as well 82 
as reducing pain, inflammation and the frequency of wound infection (16–19) . 83 
In our previous studies, we demonstrated that wIRA or wIRA/VIS treatment reduced chlamydial 84 
infectivity in permanent cell lines such as HeLa and Vero cells (20,21). Here, our goal was to study the 85 
effect of wIRA with and without visible light on an established in vitro ocular infection model to 86 
investigate the possibility of wIRA as a potential treatment for trachoma. We infected human 87 
conjunctival epithelial cells with the ocular serovar Chlamydia trachomatis B, irradiated cells and/or 88 
bacteria, either prior to infection or 40 hours post infection, and evaluated the potential reductive effect 89 
of wIRA or wIRA/VIS on chlamydial infectivity. Since the eye is a highly complex and heterogeneous 90 
organ with different anatomic structures such as the cornea, the vitreous body and the thermo- and 91 
photo-sensitive retina (22), we further investigated the effect of wIRA and wIRA/VIS irradiation on the 92 
non-infected eye. First, we focused on temperature inside the cornea, sclera and the vitreous body of 93 
isolated pigs eyes during irradiation. Pig eyes were chosen due to their similarity to human eyes in 94 
regards to size as well as histological and physiological features (23). Second, in order to investigate 95 
the effect of wIRA irradiation and temperature on the retina, we used adult and postnatal mouse retina 96 
explants, an established ex vivo organ model that is known to be particularly sensitive to stressors 97 
(24–26). Both eye models were evaluated for temperature changes upon irradiation. The retina 98 
explant model was further examined via ELISA, for activation of various markers of cytotoxicity. 99 
In summary, we demonstrated that the vitreal temperature, which can affect the neighboring thermo-100 
sensitive retina, is increased up to 38.4 °C in pig eyes at irradiation doses used to treat infection in 101 
vitro. However, wIRA/VIS does not activate markers of cytotoxicity such as phosphorylated p38, Akt, 102 
Erk or SAPK/JNK in the highly photo- and heat-sensitive retinae of adult and postnatal mice. In 103 
addition, we show that both wIRA and wIRA/VIS reduce C. trachomatis in an in vitro eye infection 104 
model. In particular, the combined irradiation of cells and EBs prior infection has a strong inhibiting 105 
effect on chlamydial infectivity. Taken together, these data indicate that this study is an important early 106 
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step in the potential introduction of wIRA or wIRA/VIS as a new, non-chemical treatment method to aid 107 
the elimination of trachoma. 108 
 109 
2. Material and Methods 110 
2.1 Preparation of isolated pig eyes 111 
Pig eyes were obtained from an abattoir and transported on ice. Post mortem time of experiments 112 
ranged from one to eight hours. Perfusion of eyes was modified from the method described by Wilson 113 
et al. (27) and Shahidullah et al. (28), (Figure 1). Briefly, the ciliary artery was cannulated with a 25G 114 
needle at the point where it enters the sclera. The eyes were placed in a water bath (with temperature 115 
adjusted for each experiment), containing Krebs’ solution [mM: NaCl, 118; KCl, 4.7; MgSO4, 1.2; 116 
CaCl2, 2.5; NaHCO3, 25; KH2PO4, 1.2; glucose, 11.5; ascorbate 0.05; glutathione, 1.0 (pH 7.4)]. The 117 
cornea was not covered by the solution. The perfusion with Krebs’ solution was performed with a 118 
peristaltic pump (Watson marlow 505U) with a flow rate of 1.4 mL/min. To mimic physiologic 119 
conditions during irradiation, the cornea was washed constantly with Krebs’ solution by the same 120 
peristaltic pump. A digital pressure transducer (Greisinger GMH5155) was used to measure the 121 
arterial pressure to ensure it did not exceed 140 mmHg. Perfusion was checked before and after each 122 
experiment. Successful perfusion was indicated by constant flow through the vortex veins. For 123 
temperature measurement, sensors of a digital thermometer (Testo735, Testo AG, Lenzkirch, 124 
Germany) were placed in the middle of the vitreous body and on the top of the cornea.   125 
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 126 
 127 
Figure 1. Schematic diagram of the pig eye perfusion model 128 
Pig eyes were placed in a water bath with Krebs’ solution, with the cornea not covered by the solution. 129 
Perfusion was performed by cannulating the ciliary artery, pumping the solution through the eyes by a 130 
peristaltic pump with a constant flow rate, representing arterial pressure, and draining through the 131 
vortex veins. The cornea was constantly washed with Krebs’ solution by the same peristaltic pump. 132 
The temperature during irradiation was measured in the middle of the vitreous body or on the top of 133 
the cornea. 134 
 135 
2.2 Irradiation of isolated pig eyes 136 
Pig eyes were exposed to wIRA/VIS with a final radiation spectrum ranging from 595 to 1400 nm for 137 
30 min using a Hydrosun 750 wIRA radiator (Hydrosun GmbH, Müllheim, Germany) with an orange 138 
filter (BTE 595, Hydrosun GmbH) at irradiation doses of 1000, 2100, 3700 and 5000 W/m2. In another 139 
set of experiments, pig eyes were  irradiated with wIRA alone for 30 min using a black filter (RG 780, 140 
Hydrosun GmbH) emitting a spectrum of 780 to 1400 nm, at 2000 W/m2, which is the corresponding 141 
irradiation dose of wIRA/VIS 2100 W/m2 if the BTE 595 is used.   142 
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2.3 Preparation, temperature exposure and irradiation of mouse retina explants 143 
All experiments were conducted according to the directive 2010/63/EU of the European Parliament. 144 
Mice were housed under conventional conditions with food and water available ad libitum and a 12-h 145 
light cycle. The eyes of adult or postnatal (10 days old, P10) C57BL/6 mice were removed after killing 146 
by cervical decapitation; the retinae with the vitreous bodies were isolated by using a binocular 147 
microscope and cultured with 500 µl medium per well [DMEM complemented with 10% FCS, 1% L-148 
glutamine, 1% nonessential amino acids, 100 U/mL penicillin, and 0.1 mg/mL streptomycin] in a 24-149 
well plate (TPP, Trasadingen, Switzerland) at 37 °C and 5 % CO2 for 30 min as previously described 150 
(29). Subsequently, well plates were placed into a circulating water bath at 37 °C or 40 °C inside of an 151 
incubator (37 °C) for another 30 min with (+wIRA) and without (Ctrl) wIRA/VIS treatment (BTE 595) at 152 
1000 W/m2. For ELISA analysis, vitreous bodies were removed from the retinae before fixation by 153 
snap freezing. Retinae were placed in cell lysis buffer and sonicated three times for 1 min each (Cell 154 
Signaling Technologies, Cambridge, UK, #9803). ELISA assay for p-p38 (Cell Signaling Technology, 155 
#7946), pAkt (Cell Signaling Technology, #7252), pErk (Cell Signaling Technology, #7177) and 156 
pSAPK/JNK (Cell Signaling Technology, #7325) was performed according to the manufacturer’s 157 
protocol.  158 
 159 
2.4 Host cells and media 160 
For cell culture experiments, human conjunctival epithelial cells (HCjE), immortalized by hTERT 161 
transfection, which were kindly donated by Prof. Ilene Gipson (Schepens Eye Research Institute, 162 
Harvard Medical School, Boston) (30), were used for the infection experiments. Reinfection 163 
experiments were performed in HeLa cells (Homo sapiens cervix adenocarcinoma, CCL-2 ATCC). For 164 
cell propagation, the cell lines were incubated at 37 °C and 5 % CO2 in growth culture medium. HCjE 165 
growth medium consisted of Keratinocyte Serum-Free Medium (GIBCO, Invitrogen, Carlsbad, CA, 166 
USA) supplemented with 25 μg/mL bovine pituitary extract (BPE, GIBCO), 0.2 ng/mL epidermal 167 
growth factor (EGF), 0.4 mM calcium chloride (Sigma-Aldrich Co., St. Louis, MO, USA) and 0.2 mg/L 168 
gentamycin (50 mg/mL, GIBCO). Neutralization medium, composed of Dulbecco`s Modified Eagle 169 
Medium/Nutrient Mixture F-12 (DMEM/F12, GIBCO) with 10 % fetal calf serum (FCS, BioConcept, 170 
Allschwil, Switzerland) was used for the thawing of cells, serial passaging and infection of HCjE, as 171 
previously described (30). 172 
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HeLa growth medium consisted of Minimal Essential Medium (MEM) with Earle’s salts, 25 mM 173 
HEPES, without L-Glutamine (GIBCO) supplemented with 10 % fetal calf serum (BioConcept), 4 mM 174 
GlutaMAX-I (200mM, GIBCO), 0.2 mg/mL gentamycin (50 mg/mL, GIBCO) and 1% MEM Non-175 
Essential Amino Acids (MEM NEAA, 100x, GIBCO). 176 
For infection experiments, cells were seeded on glass coverslips (13 mm diameter, Sterilin Limited; 177 
Thermo Fisher Scientific, Waltham, MA, USA), which were placed in 24-well plates (Techno Plastic 178 
Products AG (TPP), Trasadingen, Switzerland). Prior to seeding HCjE, coverslips were coated with 50 179 
μg/mL Rat-Tail Collagen I (Discovery Labware, Inc., Bedford, MA, USA) diluted in 0.02 N acetic acid 180 
(Carl Roth, Karlsruhe, Germany). When cells reached a confluency of 80-90 %, they were plated at a 181 
density of 1.5x105 cells/well and grown for 48 hours in 1 mL growth medium. HeLa cells were 182 
processed as previously described (20).  183 
 184 
2.5 Chlamydial strains 185 
In the present study, Chlamydia (C.) trachomatis, serotype B (strain HAR-36, VR-573 ATCC, kindly 186 
provided by T. Barisani-Asenbauer, Vienna, Austria) was used for all infection experiments with HCjE 187 
cells. The strain was propagated and stored at -80 °C as previously described (20), in LLC-MK2 cells 188 
(CCL-7 ACCT, kindly provided by M. Donati, Bologna, Italy) as reported previously (31) . 189 
 190 
2.6 Irradiation of HCjE and temperature measurement during irradiation 191 
In this study, infected and non-infected cells were exposed either to wIRA alone (RG 780) or wIRA/VIS 192 
(BTE 595) for 30 min at 2000 W/m2 and 2100 W/m2, respectively. 193 
Aiming for a stable temperature during irradiation, 24-well plates were placed into a circulating water-194 
bath (SC100, Thermo Fisher Scientific), which served as a cooling system with an adjusted 195 
temperature of 37 °C. Intra-well temperature was checked every 5 min during 30 min of irradiation with 196 
a Voltcraft thermometer (Type 2ABAc, Philips, Kassel, Germany) as previously described (20).  197 
 198 
2.7 Determination of cell viability  199 
2.7.1 AlamarBlue assay 200 
10 % AlamarBlue dye (Biozol, Eching, Germany) was added to the wells immediately after irradiating 201 
non-infected HCjE once or four times (0 h, 2 h, 5 h and 8 h) for 30 min with 2000 W/m2 wIRA or 2100 202 
W/m2 wIRA/VIS. Plates were then incubated for 3 h at 37 °C and fluorescence was determined at 560 203 
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nm excitation and 590 nm emission wavelength (LS55 luminescence spectrometer, Perkin-Elmer) as 204 
previously described (32). Heat denatured cells (h.d.) served as a positive control.  205 
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2.7.2 Evaluating average number of cells per field 206 
After fixation of cell cultures in 1 mL methanol for 10 min, nuclei were stained with 4’,6-Diamidin-2’-207 
phenylindoldihydrochlorid (1:1000, DAPI, 1 g/mL, Molecular Probes, Eugene, OR, USA) and 208 
coverslips were mounted on glass slides using FluoreGuard Mounting (Hard Set, ScyTek Laboratories 209 
Inc., Logan, UT, USA) before examination using a DMLB fluorescence microscope (Leica 210 
Microsystems, Wetzlar, Germany). Briefly, the number of nuclei per high-power field was counted in 211 
ten microscopic fields at 1000-fold magnification on oil immersion with a 100x objective (PL FLUOTAR 212 
100x/1.30, OIL, ∞/0.17/D, Leica Microsystems) and a 10x ocular objective (Leica L-Plan 10x/25M, 213 
Leica Microsystem), followed by determination of the mean value. The mean number of nuclei per field 214 
of irradiated samples was then compared to control (non-irradiated) samples. 215 
 216 
2.8 Experimental design of infection 217 
2.8.1 Irradiation of infected HCjE at 40 hours post infection (hpi) 218 
HCjE were seeded on a 24-well plate, incubated for 48 h and infected with EBs at a multiplicity of 219 
infection (MOI) of 0.1 or 1. Briefly, EBs were diluted in 1 mL neutralization medium per sample and 220 
used to inoculate 100% confluent HCjE monolayers. Plates were then centrifuged for 1 hour at 1000 g 221 
and 25 °C. Afterwards, inocula were aspirated and replaced by 1 mL incubation medium without 222 
gentamycin for further incubation of plates at 37° C and 5 % CO2. At 40 hpi, infected monolayers were 223 
irradiated with wIRA alone or wIRA/VIS, as described in 2.6, and incubated for 3 h before they were 224 
fixed in methanol for immunofluorescence or collected for titration by sub-passage as previously 225 
described (20) (Figure 2A). Non-irradiated cultures were used as controls. 226 
 227 
2.8.2 Irradiation of EBs and HCjE prior to infection  228 
For this experiment, HCjE were seeded and incubated for 48 h. During incubation, cell monolayers 229 
were irradiated four times 8 h, 6 h, 3 h and immediately before infection with EBs, which had been 230 
exposed to irradiation by transferring 1 mL of EB-containing medium to a cell-free 24-well plate for 231 
treatment as previously established (20,21). Irradiation was performed with either wIRA alone or 232 
wIRA/VIS for 30 min as shown in 2.6.  233 
In total, there were four conditions: i) non-irradiated cells with non-irradiated EBs (control, E-C-), ii) 234 
irradiated cells with non-irradiated EBs (E-C+), iii) non-irradiated cells with irradiated EBs (E+C-) and 235 
iv) irradiated cells with irradiated EBs (E+C+). After infection with EBs, plates were incubated for 43 h 236 
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at 5 % CO2 (37 °C) and were then either fixed and stained for immunofluorescence microscopy or 237 
collected for reinfection as described in 2.9. (Figure 2B). 238 
 239 
 240 
 241 
Figure 2. Study design of the eye infection model. (2 columns) 242 
Human conjunctival epithelial cells (HCjE) were seeded and incubated for 48 h prior to infection with 243 
EBs (C. trachomatis serotype B) at a multiplicity of infection (MOI) 0.1 or 1. After centrifugation at 1000 244 
g for 1 h (25 °C), infected cultures were incubated and samples were collected for titration by sub-245 
passage at 43 h post infection (hpi). Time of irradiation treatment (prior or post infection) depended on 246 
the experiment. Irradiation was performed either with wIRA alone (2000 W/m2, RG 780 filter) or wIRA 247 
in combination with visible light (2100 W/m2, BTE 595) for 30 min per treatment. (A) Infected cell 248 
cultures were irradiated at 40 hpi (red arrow). (B) Cells were irradiated four times (8 h, 6 h, 3 h, 0 h) 249 
before they were infected with EBs, which had been irradiated or not immediately prior to infection (red 250 
arrows with dashed lines).  251 
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2.9 Immunofluorescence staining and microscopy 252 
Prior to immunofluorescence staining, cultures were fixed in methanol at 40 hpi or 43 hpi. Indirect 253 
immunofluorescence assays (IFA) were performed with a primary Chlamydiaceae family-specific 254 
mouse monoclonal antibody (1:200, LPS, Clone ACI-P, Progen, Heidelberg, Germany), detecting the 255 
chlamydial lipopolysaccharide and a secondary Alexa Fluor 488-goat anti-mouse antibody (1:500, 256 
Molecular Probes, Eugene, OR, USA), as previously described (20). DNA was stained with DAPI 257 
(1:1000, 1 g/mL). After immunolabeling, coverslips were fixed onto glass slides and examined with a 258 
DMLB fluorescence microscope as described in 2.7.2. Samples from the original infection were 259 
screened at 1000-fold magnification on oil immersion, counting the number of nuclei and chlamydial 260 
inclusions in ten fields to determine the infection rate, whereas the number of inclusions per field was 261 
determined in 30 fields per coverslip for reinfection experiments at 200-fold magnification using a 20x 262 
objective (PL FLUOTAR 20x/0.50 PH2, ∞/0.17/B) and a 10x ocular objective (Leica L-Plan 10x/25 M, 263 
Leica Microsystems) as previously described (21). 264 
 265 
2.10 Titration by sub-passage / Reinfection experiments 266 
Samples for titration by sub-passage were collected at 43 hpi by scraping the cell monolayer into the 267 
medium. The samples were then stored at -80°C. After thawing, infected cells were sonicated for 5 268 
min with a sonicator (Brandson 250 Sonifier, Danbury, CT, USA) and used for titration by sub-passage 269 
in HeLa cells as previously described (20,33). 270 
Briefly, a serial dilution was performed on a 24-well plate seeded with HeLa cells before centrifugation 271 
for 1 hour at 1000 g and replacement of the inoculum with 1 mL of HeLa growth medium (without 272 
gentamycin) supplemented with 1 g/mL cycloheximide (Sigma-Aldrich). At 40 hpi, cultures were fixed 273 
and immunolabeled as described in 2.9. For analysis, the number of inclusions at 200-fold 274 
magnification in 30 random microscopic fields were counted and the number of inclusion-forming units 275 
(IFU) in undiluted inoculum was determined and expressed as IFU per mL as previously described 276 
(32). 277 
 278 
2.11 Statistical analysis 279 
All statistical analyses were performed with the GraphPad Quickcalcs software 280 
(www.graphpad.com/quickcalcs) as previously described (21). If not stated otherwise, all results are 281 
presented as means ± standard deviation (SD) of the indicated number of experiments. The 282 
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significance of differences was estimated by the unpaired t test for all cell culture experiments and a p-283 
value of <0.05 was considered significant. One-way ANOVA followed by Tukey-test for multiple groups 284 
was used for comparison of temperature increase in the pig eyes experiments and experiments with 285 
mouse retina explants after varying doses of wIRA. Unpaired two-tailed student’s t-test was used for 286 
ELISA analysis. For all analyses a CI = 95% with *p < 0.05, **p < 0.01 and ***p < 0.001 was defined 287 
as statistically significant. 288 
 289 
3. Results 290 
3.1 wIRA-induced temperature increase is not altered by the visible light component in intra-291 
well or cornea but is slightly elevated in the vitreous body.  292 
In a previous study, we showed that visible light (380-780 nm) significantly contributed to the increase 293 
of intra-well temperature at high doses of irradiation in in vitro cultured cells (21). Consequently, we 294 
investigated whether this significant rise in intra-well temperature also occurs at a visible light 295 
spectrum of 595 to 780 nm, and how the temperature curve compares to those generated in ex vivo 296 
models. Briefly, we evaluated the temperature curve both within the wells of a 24-well plate of cultured 297 
cells and in ex vivo in pig eyes during irradiation with wIRA alone or with wIRA/VIS for 30 min. For the 298 
in vitro infection model, HCjE cells were seeded on coverslips in 24-well plates and the intra-well 299 
temperature was measured at the bottom of the wells every 5 min. For wIRA alone, the starting 300 
temperature was 35.41 °C ( 0.25 °C) followed by a rapid increase to 37.23 °C ( 0.2 °C) within 5 min 301 
before reaching a plateau of approximately 37.7 °C after 10 min of irradiation. The temperature curve 302 
of wIRA/VIS looked similar to that of wIRA alone, though the starting temperature was slightly lower 303 
with 34.39 °C ( 0.73 °C, Figure 3A, left panel). After 30 min of irradiation, the final intra-well 304 
temperature was 37.71 °C ( 0.12 °C), which was not significantly different from wIRA/VIS irradiation 305 
(37.54  0.07 °C, Figure 3A, right panel).  306 
The vitreal temperature of perfused pig eyes was adjusted to the physiological temperature of 34 °C 307 
(34). WIRA/VIS was then applied for 30 min, which led to a rapid increase in temperature within the 308 
first 10 min of treatment before reaching a plateau similar to that of irradiated HCjE in a 24-well plate 309 
(Figure 3B, left panel). Interestingly, we found that the final vitreal temperature was significantly lower 310 
following wIRA/VIS irradiation (37.64 °C  0.34 °C) compared to wIRA alone (38.4  0.73 °C, Figure 311 
3B, right panel). In contrast to irradiation of HCjE and the vitreous body, where the mean temperature 312 
increased up to 38 °C in the course of 30 min and a plateau was reached within the first 5-10 min, 313 
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average surface temperature of the cornea did not exceed 35 °C. Initial corneal temperature started at 314 
33.63 °C ( 0.15 °C) and 33.66 °C ( 0.06 °C) and rose to 34.9 °C ( 0.62 °C) and 34.5 °C ( 0.61 °C) 315 
after 30 min for wIRA alone and wIRA/VIS, respectively (Figure 3C, left panel). Similar to irradiation of 316 
HCjE, the temperature differences between the two irradiation spectra groups were not significant 317 
(Figure 3C, right panel). 318 
 319 
 320 
 321 
Figure 3. The visible light component (595-780 nm) does not significantly increase intra-well, 322 
vitreal or corneal temperature. (1.5 columns) 323 
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(A) Monolayers of HCjE seeded on a 24-well plate were irradiated for 30 min with either wIRA alone 324 
(RG 780 filter, 2000 W/m2) or wIRA and visible light (BTE 595, 2100 W/m2). The mean intra-well 325 
temperature of three wells per condition was evaluated every 5 min in three independent experiments. 326 
Shown is the temperature profile for each condition in the course of irradiation (left panel) and the 327 
mean intra-well temperature after 30 min of irradiation (right panel; mean ± SD; n.s. not significant; t 328 
test). Additionally, perfused pig eyes were irradiated similarly after adjusting (B) the vitreal or (C) the 329 
corneal temperature to 34 °C whereupon the temperature was measured constantly (mean ± SD; n=3 330 
for wIRA alone; n=5 for wIRA/VIS, * p < 0.05; one way ANOVA). 331 
 332 
3.2 WIRA/VIS increases vitreal and corneal temperature of constantly perfused pig eyes in a 333 
dose dependent manner. 334 
As determined in our previous experiment, wIRA/VIS and wIRA treatments result in similar 335 
temperature curves, despite varying vitreal temperature, after 30 min. Therefore, in order to further 336 
investigate the influence of the irradiation dose in an ex vivo model, we irradiated perfused pig eyes 337 
with wIRA/VIS for 30 min at 1000, 2100, 3700 and 5000 W/m2. As expected, we found a positive 338 
correlation between temperature increase and irradiation dose, with each dose significantly varying 339 
from the other. For example, the vitreal temperature was significantly increased during irradiation at 340 
1000 W/m2 (p = 0.0025) and the final vitreal temperature was 35.8 °C ± 0.4 °C after 30 min, in contrast 341 
to a final temperature of 41.3 °C (± 0.7 °C) following treatment at 5000 W/m2 (Figure 4A). 342 
In opposition to the vitreous body results, continuous temperature measurement of the constantly 343 
perfused corneal surface resulted in a different irradiation dose response. Neither 1000 W/m2 nor 344 
2100 W/m2 of wIRA/VIS induced a significant increase against the physiological start temperature of 345 
34 °C (34–36) (Figure 4B). However, higher doses led to a significant temperature increase after 30 346 
min at 3700 W/m2 and 5000 W/m2 with 38.6 °C ± 1.13 °C and 41.13 °C ± 0.93° C observed, 347 
respectively.   348 
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 349 
 350 
Figure 4. wIRA/VIS increases vitreal and corneal temperature of constantly perfused pig eyes 351 
in a dose dependent manner. (2 columns) 352 
Perfused pig eyes were irradiated with wIRA and visible light (BTE 595) at varying irradiation doses 353 
(1000, 2100, 3700 and 5000 W/m2) for 30 min after initial adjustment of the vitreal or corneal 354 
temperature to 34 °C. The temperature (A) within the vitreous body and (B) on the cornea was 355 
continuously measured during irradiation (mean ± SD; n=3; n.s. not significant, * p < 0.05, ** p < 0.01; 356 
one way ANOVA). 357 
 358 
3.3 Retina explants of adult and postnatal mice withstand temperature exposure up to 40 °C 359 
Irradiation of perfused pig eyes revealed a strong dose-dependent increase in vitreal temperature. 360 
Since an increase of temperature within the vitreous body may be associated with elevated 361 
temperature of the neighboring retinal tissue, we further analyzed the impact of hyperthermia on the 362 
expression levels of general molecular markers of cytotoxicity in the retina. Briefly, retinal explants of 363 
mice were exposed to 40 °C for 30 min in the presence or absence of wIRA/VIS at 1000 W/m2. 364 
Retinae of both adult and postnatal mice (10 days, P10) were used for the experiment since the latter 365 
corresponds with the retinal developmental stage of human neonates and infants. Measuring the 366 
levels of phosphorylated stress kinases p38, Akt, Erk 1/2 and SAPK/JNK by ELISA, we observed no 367 
significant changes immediately (0 h), 3 h or 24 h following treatment in retinae of adult mice (Figure 368 
5A). The only increase observed were the pSAPK/JNK levels by a factor of 1.9 immediately after both 369 
40 °C alone and in combination with irradiation in the retinae of postnatal mice (Figure 5B). At the later 370 
time points (3 h and 24 h), no changes in the level of stress kinases were observed in either adult or 371 
postnatal retinae (Figure 5).   372 
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 373 
 374 
Figure 5. Levels of general and molecular markers of cytotoxicity are unaffected by both 375 
hyperthermia alone or in combination with irradiation in adult and postnatal mouse retina 376 
except for a rapid increase of pSAPK/JNK in the postnatal retina. (1 column) 377 
Retinal explants of (A) adult or (B) postnatal mice (P10) were irradiated with wIRA and visible light 378 
(BTE 595, 1000 W/m2) for 30 min. Temperature was adjusted to 37 or 40 °C during the irradiation 379 
process. Tissues were subsequently collected after 0 h, 3 h and 24 h at 37°C. Measurements for the 380 
levels of p-p38, pAkt, pErk1/2 and pSAPK/JNK by ELISA assay are shown. Values are normalized to 381 
the 37 °C control values (mean  SD; n=3).  382 
 383 
3.4 Cell viability is not reduced following irradiation 384 
Determination of cell viability is an important in vitro parameter to detect potentially harmful effects of a 385 
treatment method. In a previous study, we showed that the viability of permanent cell lines (HeLa, 386 
Vero) was not negatively affected by wIRA/VIS even after long-term treatment for more than four 387 
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hours up to one day after exposure (20). In order to exclude possible damaging effects of wIRA and 388 
wIRA/VIS irradiation to the primary conjunctival cell line HCjE, we measured the cell viability post 389 
treatment using two different methods.  390 
First, cell metabolism was assessed with the AlamarBlue assay after single-dose or four times 391 
irradiation of HCjE by adding 10 % AlamarBlue immediately after the last treatment and processing 392 
the samples as described in 2.7.1. We found that irradiation of HCjE with wIRA alone led to a slight 393 
reduction in cell viability to 86.99 % ( 3.96 %) and 78.54 % ( 8.67 %) of the control value after single 394 
and four times irradiation, respectively, which was significant in both cases (p = 0.0432 after single, p 395 
= 0.0488 after four times irradiation, Figure 6A). However, wIRA/VIS did not significantly reduce the 396 
cell viability, with reductions to 95.37 %  0.65 % for single (p = 0.0525) and 88.13 %  6.38 % for four 397 
times irradiation versus control values (p = 0.0999, Figure 6B). 398 
Second, we calculated the mean number of cells per high-power field in order to identify possible cell 399 
loss due to treatment. There was no significant decrease in the average number of cells in irradiated 400 
HCjE compared to non-irradiated HCjE regardless of treatment. In detail, we found that wIRA alone 401 
and wIRA/VIS were associated with 21.67 cells/field  5.33 and 21.67 cells/field  2.04, respectively, 402 
compared to the non-irradiated control with 21.48 cells/field  2.69 following single-dose irradiation 403 
(Figure 6C). Similarly, after irradiating HCjE four times, the number of cells per field was 22.5  0.78 404 
for wIRA/VIS and 21.73  2.41 for wIRA alone. Non-irradiated cultures yielded 21.33 cells/field  1.21 405 
(Figure 6D).  406 
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Figure 6. Cell viability of HCjE post irradiation. (2 columns) 408 
(A-B) present the results of the AlamarBlue assay as mean ± SD (n  2; t test, * p > 0.05). Briefly, 10 409 
% AlamarBlue dye was added to the medium for three hours immediately after irradiating HCjE (A) 410 
once or (B) four times with either wIRA alone (RG 780 filter, 2000 W/m2) or wIRA and visible light 411 
(BTE 595, 2100 W/m2) for 30 min per treatment. Heat-denatured samples (h.d.) were included as 412 
killing controls. For (C-D), the number of nuclei per field at 1000x magnification was evaluated in 10 413 
fields per condition 43 hours post infection (hpi) with C. trachomatis serotype B. Shown is the mean 414 
number of nuclei following (C) single-dose irradiation 40 hpi, or (D) after irradiation 8 h, 6 h, 3 h and 415 
immediately prior infection (mean ± SD; n.s. not significant; n  3; t test). Non-infected and non-416 
irradiated HCjE cultures were used as control. Each irradiation was applied for 30 min with either 417 
wIRA alone (RG 780, 2000 W/m2) or wIRA and visible light (BTE 595, 2100 W/m2).   418 
  21 
3.5 Chlamydial infectivity is reduced following single-dose irradiation of mature chlamydial 419 
infections in HCjE  420 
We have previously established that infections with the genital C. trachomatis serovar E strain or C. 421 
pecorum isolated from a swine abortion were significantly inhibited when wIRA/VIS (380-1400 nm) or 422 
wIRA alone (780-1400 nm) was applied 40 h post infection of HeLa or Vero cells, regardless of the 423 
infectious dose and the radiation spectrum (20,21). We wished to confirm these results by 424 
investigating the effects of wIRA alone or wIRA with a partial visible light spectrum (595-780 nm, BTE 425 
595) on mature chlamydial inclusions in HCjE. For this purpose, we infected monolayers with C. 426 
trachomatis B EBs, irradiated them at 40 hpi for 30 min, and collected samples three hours later for 427 
titration by sub-passage as described in 2.11. Cultures were infected with doses of MOI 0.1 (Figure 7) 428 
and MOI 1.0 (Figure S1A) and irradiated with wIRA/VIS or wIRA alone at 2100 W/m2 and 2000 W/m2, 429 
respectively. 430 
Surprisingly, we found that while wIRA alone reduced the infectivity of mature chlamydial inclusions by 431 
35.27 % ( 8.16 %) (Figure 7A), wIRA/VIS reduced it by 53.81 %  4.62 % at MOI 0.1 (Figure 7B). 432 
The difference between the two irradiation spectra was significant (p = 0.0298). In contrast, there was 433 
no significant difference between the two infectious doses (MOI 0.1, 1) following treatment with wIRA 434 
alone (p = 0.721, Figure S1A). 435 
 436 
 437 
 438 
Figure 7. Infectivity is reduced following single-dose irradiation of mature chlamydial 439 
infections in HCjE. (1 column) 440 
HCjE were infected with C. trachomatis serotype B at MOI 0.1 and irradiated or not 40 hours post 441 
infection (hpi) for 30 min with (A) wIRA alone (RG 780, 2000 W/m2) or (B) wIRA and visible light (BTE 442 
595, 2100 W/m2). Cultures were collected at 43 hpi for titration by sub-passage. Inclusion-forming 443 
units per mL (IFU/mL) are shown as percent of non-irradiated controls (mean ± SD; * p < 0.05; n = 3; t 444 
test). 445 
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3.6 Irradiation of EBs and cells prior to infection enhances the anti-chlamydial effect 446 
In previous publications (20,21), we showed that irradiation of C. pecorum and C. trachomatis E EBs 447 
prior to infection of either Vero or HeLa cells led to reduced chlamydial infectivity. 448 
In this study, we wished to confirm these findings in an eye infection model by subjecting C. 449 
trachomatis B EBs to wIRA alone (2000 W/m2) and wIRA/VIS (2100 W/m2) for 30 min before infection 450 
of HCjE. In addition, we further investigated the effect of treating cells alone or in combination with EB 451 
treatment by irradiating cells 8 h, 6 h, 3 h and immediately prior to infection with irradiated or non-452 
irradiated EBs, which resulted in four conditions for both radiation spectra: a) non-irradiated cells 453 
infected with non-irradiated EBs (control, E-C-), b) irradiated cells infected with non-irradiated EBs (E-454 
C+), c) non-irradiated cells infected with irradiated EBs (E+C-) and d) irradiated cells infected with 455 
irradiated EBs (E+C+). 456 
We found that irradiating both EBs and cells led to the strongest decrease in infectivity compared to 457 
non-irradiated controls for both wIRA alone and wIRA/VIS, with decreases to 73.54 %  0.55 % 458 
(Figure 8A) and 86.85 %  0.92 % (Figure 8B) of the control, respectively. Next, irradiation of EBs 459 
alone led to a strong reduction in the infectivity of EBs, especially in the presence of a visible light 460 
component (wIRA alone: 45.73 %  7.80 %, wIRA/VIS: 30.54 %  2.96 % of non-irradiated controls). 461 
However, treatment of only HCjE prior to infection also led to a significant reduction in chlamydial 462 
infectivity post infection for both wIRA alone (35.37 %  1.53 %) and in combination with visible light 463 
(wIRA/VIS, 33.96 %  1.54 %) versus controls. Interestingly, while the effect of irradiating cells with 464 
wIRA alone compared to wIRA/VIS was not significantly different (p = 0.3235), wIRA/VIS led to a 465 
significantly more efficient reduction compared to wIRA alone for both EB treatment (p = 0.0344) and 466 
the combination treatment of both EBs and cells (p < 0.0001). Similarly to treatment of mature 467 
chlamydial inclusions (3.5) and previous studies (21), there was no significant difference between the 468 
infectivity of EBs at MOI 1 (39.95 %  7.94 % to non-irradiated control) and MOI 0.1 (42.25 %  10.68 469 
%) after irradiation with wIRA alone (Figure S1B).  470 
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 471 
 472 
Figure 8. Irradiation of C. trachomatis B EBs and HCjE prior to infection enhances the anti-473 
chlamydial effect. (1.5 columns) 474 
HCjE were irradiated (C+) or not (C-) four times 8 h, 6 h, 3 h and immediately prior to infection with 475 
irradiated (E+) or non-irradiated (E-) C. trachomatis serotype B EBs. After 43 h of incubation, cultures 476 
were collected for titration by sub-passage. Shown is the mean ± SD (* p < 0.05; n  3; t test) of 477 
inclusion-forming units per mL (IFU/mL) as percent of a non-irradiated control (E-C-). Each irradiation 478 
treatment was performed for 30 min either with (A) wIRA alone (RG 780, 2000 W/m2) or (B) wIRA in 479 
combination with visible light (BTE 595, 2100 W/m2). 480 
 481 
4. Discussion  482 
Blinding trachoma is still endemic in many parts of the world even though the WHO has been 483 
combating the disease since 1997 (1–4). To date, antibiotic treatment as part of the SAFE strategy 484 
has not produced the desired results, leaving a considerable number of people still infected despite 485 
therapy (4,5). This being the case, the aim of our study was to develop a possible new, non-chemical 486 
treatment method for trachoma patients using near-infrared A radiation. This approach was evaluated 487 
by using an in vitro infection cell culture model and two ex vivo eye models. 488 
Since the eye is one of the most photosensitive organs, careful examination of the eye during and 489 
after irradiation treatment is crucial to exclude any damage or unwanted side effects. It is known that 490 
wIRA has a thermal component (18,20,37), which prompted us to examine temperature during 30 min 491 
of irradiation with either wIRA or wIRA/VIS in perfused pig eyes. The initial temperature was set to 34 492 
°C to represent the physiological in vivo eye temperature. Temperature measurements within the eye 493 
are challenging and reports of ocular temperature in the literature show variable results. Salcedo-494 
Villanueva et al. determined a mean vitreous temperature in human eyes of 33.04 °C during cataract 495 
surgery (38), while Landers et al. found the mid-vitreous temperature to be between 33.2 and 34.7 °C 496 
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(34). The temperature was similar in anaesthetized pigs, reporting a mean of 34.7-35.8 °C for the 497 
vitreous body and 34.3 °C for the aqueous chamber. Temperature near the retina was found to be 498 
slightly higher (34.4−35.3 °C) as it contains blood vessels and is consequently influenced by the body 499 
temperature (36).  500 
In our ex vivo model of perfused pig eyes, we found that the corneal temperature never exceeded 35 501 
°C at radiation doses of 2000 W/m2 wIRA and 2100 W/m2 wIRA/VIS. Since the vitreal temperature 502 
after irradiation with the dose of 2100 W/m2 was 37 °C, which equals the physiological body 503 
temperature, we chose this dose as a potential therapeutic radiation dose and used it in all further 504 
experiments. The temperature difference between irradiation with wIRA and irradiation with wIRA/VIS 505 
on the cornea was not significant. The only slight temperature elevation in our ex vivo model is a 506 
promising result regarding possible future administration in vivo. However, the actual in vivo 507 
temperature could be different, given the fact that the cornea is an avascular tissue. Thus corneal 508 
temperature depends on the temperature of the eye lids, while the lids are closing, and on the ambient 509 
temperature as well as the aqueous temperature when the eye is opened (39). 510 
Similar results were obtained in the cell culture experiments. Even though the initial intra-well 511 
temperature was slightly higher with wIRA alone, there was no significant difference amongst the 512 
filters after the irradiation period of 30 min. In contrast to these findings, the final temperature inside 513 
the vitreous body was significantly higher following irradiation with wIRA alone compared to irradiation 514 
with wIRA/VIS. A possible explanation for this could be that the vitreous body was the only closed 515 
system in our experiments, thus accumulating heat energy, whereas cornea and wells were exposed 516 
to ambient temperature.  517 
Several studies have aimed to evaluate consequences of increased temperatures on ocular 518 
structures. Some authors claimed that hyperthermia induced by infrared radiation may lead to cataract 519 
formation (40,41), while Wolbarsht hypothesized that this process was not thermal but 520 
photochemically-induced (42). In a more recent publication, Yu et al. performed in vivo experiments 521 
with rats and found that exposure to 197  W/cm2 1090-nm infrared reflectrography (IRR) for eight 522 
seconds led to a temperature increase of 10 °C at the limbus and 26 °C near the retina, which induced 523 
cataract (43). However, Yu et al. used a laser as a source for IRR, which contains more heat radiation. 524 
In wIRA, part of the heat energy is filtered through the water cuvette (16), so heating of the tissue 525 
should be rather moderate. 526 
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The retina belongs to the main structures of the eye, which converts electromagnetic radiation into 527 
neuronal signals (44). In order to exclude damage following wIRA treatment, we exposed retina 528 
explants of postnatal and adult mice to different temperatures of up to 40 °C with or without the 529 
combination of wIRA irradiation and measured the expression of general and molecular cytotoxicity 530 
markers. No changes regarding expression levels in adult retinae were observed, even in samples 531 
with temperature treatment of 40 °C in combination with wIRA. In retinal tissue of postnatal mice only 532 
the levels of pSAPK/JNK were increased directly after treatment with temperature alone and in 533 
combination with wIRA. These results suggest that even in a highly vulnerable model, there is no 534 
significant increase in the level of observed stress markers of the retina after wIRA application or 535 
temperature exposure up to 40 °C. Iwami et al. recently described a laser-induced temperature of 50-536 
52 °C to be the threshold for retinal pigment epithelium (RPE) cell death. Moreover, they observed that 537 
sub-lethal temperatures of about 43 °C increase cell defense mechanisms against oxidative stress 538 
(45). These mechanisms can be induced by hyperthermia (46). Though, as mentioned before, these 539 
temperatures of lethal hyperthermia are not expected during wIRA exposure (16). 540 
Cell viability following wIRA irradiation was further examined in vitro. Previously, we demonstrated that 541 
wIRA/VIS does not reduce cell metabolism of HeLa or Vero cells, nor were there any signs of 542 
cytotoxicity in HeLa cells (20). In our recent experiments, metabolism of the conjunctival cell line HCjE 543 
was only slightly reduced using the highest achievable dose of wIRA without visible light. However, 544 
irradiation with wIRA/VIS did not result in any considerable decrease of metabolic activity compared to 545 
the non-irradiated controls after single or four times irradiation for 30 min. We hypothesized that since 546 
HCjE is a healthy cell line, they are probably more susceptible to stressors than cell lines from a 547 
cancerous origin such as HeLa, possibly explaining the slight viability decrease after irradiation with 548 
wIRA alone. A recent study supports our findings, stating that metabolic activity was even enhanced 549 
after wIRA irradiation in another continuous cell line (47). Knels et al. irradiated Swiss albino mouse 550 
embryonic fibroblast cell-line NIH/3T3 cultures with 300 W/m2 (wIRA, 780-1400 nm) for either 60 or 551 
120 min demonstrating that the overall metabolic rate was increased post irradiation. Furthermore, it 552 
was significantly higher in all samples at 40 °C regardless of wIRA treatment compared to samples at 553 
37 °C.  554 
Furthermore we could not detect any cell loss in HCjE monolayers irradiated either with wIRA or 555 
wIRA/VIS by enumerating nuclei per microscopic field as another indicator for potential cytotoxic 556 
effects. 557 
  26 
Based on our previous studies with C. pecorum in Vero cells and C. trachomatis E in HeLa cells, we 558 
established a trachoma infection model using the ocular strain C. trachomatis B in HCjE cells and 559 
irradiated samples at 40 hours post infection. The reduction of chlamydial infectivity was significant 560 
with both filters and similar to the results of previous experiments (20,21). The reduced infectivity 561 
following treatment with wIRA alone was not influenced by the chlamydial infection dose (MOI 0.1, 1). 562 
Interestingly, in cultures infected with only MOI 0.1, irradiation with wIRA/VIS decreased the 563 
chlamydial infectivity more efficiently than wIRA alone. However, in our previous study with cancerous 564 
cell lines (21), we did not see any additional reducing effect of VIS on mature chlamydial inclusions, 565 
hence this outcome could again be dependent on the characteristics of the non-cancerous cell line. 566 
The impact of VIS was further analyzed in another experiment, in which we irradiated EBs and HCjE 567 
prior to infection. Here we demonstrated that the relative decrease in chlamydial infectivity was 568 
significantly higher following treatment of EBs with wIRA/VIS compared to wIRA alone, which is in 569 
accordance with our previous findings (21). In addition, the visible light component had no significant 570 
influence on the chlamydial infectivity if only cells were irradiated prior infection leading to the 571 
conclusion that extracellular C. trachomatis B EBs are sensitive to visible light. 572 
Furthermore we found that, independent of the visible light component, the highest decrease of 573 
chlamydial infectivity occurred if both EBs and cells were irradiated prior infection. Surprisingly, the 574 
number of chlamydial inclusions was also reduced following irradiation of uninfected HCjE alone 575 
without any direct treatment of Chlamydia leading us to hypothesize that a wIRA-induced cellular 576 
protective effect is stimulated against subsequent chlamydial infection. According to several other 577 
studies, this might be due to an increased cell metabolism (16–19). Knels et al. recently discovered 578 
that wIRA irradiation of fibroblast cultures not only enhances metabolic activity, but also that it has a 579 
protective effect on cells, improving their viability under oxidative stress. The authors consider a 580 
possible beneficial effect on mitochondria (47).  581 
In summary, we demonstrate that irradiation with wIRA/VIS or wIRA alone reduces chlamydial 582 
infectivity in primary human conjunctival epithelial cells infected with the trachoma strain C. 583 
trachomatis B at doses not reducing the cell viability.  584 
The required wIRA doses, which trigger this effect, cause only physiological temperatures on the 585 
cornea and in the vitreous body of perfused pig eyes. However, since these structures directly 586 
neighbor the retina, we further analyzed possible effects of hyperthermia on this neuronal tissue. 587 
Since hyperthermia has been shown to influence the activation of the mitogen-activated kinase 588 
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(MAPK) and also the Akt pathway in parts of the brain (48), we elucidated the phosphorylation levels 589 
of p38 MAPK, Erk, JNK and Akt in the retina of adult and postnatal mice after 30 min of 40 °C. Except 590 
for the postnatal retina, we failed to detect significant changes in the activation of these stress related 591 
pathways, which indicates a lack of degenerative stimuli after this treatment, at least in the adult 592 
situation.  593 
In particular, our results show that the addition of VIS contributes to the antimicrobial effect of this non-594 
chemical method. EBs appear to be highly sensitive to exposure to the visible light component 595 
specifically. There was also a greater reduction in the infectivity of mature chlamydial inclusions 596 
following exposure to wIRA/VIS compared to wIRA alone. Interestingly, the temperature increase in 597 
the vitreous body of pig eyes following wIRA/VIS exposure was less pronounced compared to 598 
irradiation with wIRA alone, leading us to conclude that, in addition to an already described irradiation 599 
dose effect, the radiation spectrum (780-1400 nm, 595-1400 nm) may additionally influence the effect 600 
of irradiation on chlamydial infection and tissue. 601 
We failed to observe wIRA-induced damage of HCjE or retinal tissue. Instead, we discovered a 602 
possible beneficial cellular effect, suggesting that near-infrared radiation with or without visible light 603 
triggers cell mechanisms that protect the cell from chlamydial infections. Our study is the first of its 604 
kind demonstrating that near-infrared A radiation reduces chlamydial infections in primary human 605 
conjunctival epithelial cells in vitro without corresponding negative consequences in ex vivo models, 606 
providing the basis to introduce irradiation as a potential non-chemical method to treat trachoma.  607 
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